227 related articles for article (PubMed ID: 987850)
1. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
Cory JG; Mansell MM; Whitford TW
Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of inosine dialdehyde (NSC 118994) in the inhibition of proliferation of tumor cells in culture.
Plagemann PG; Graff JC; Behrens M
Cancer Res; 1977 Jul; 37(7 Pt 1):2188-95. PubMed ID: 193637
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
Cory JG; Fleischer AE
Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
[TBL] [Abstract][Full Text] [Related]
4. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivatives of adenosine, adenosine 5'-monophosphate, and adenosine 5'-triphosphate.
Cory JG; Mansell MM
Cancer Res; 1975 Feb; 35(2):390-6. PubMed ID: 1109803
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RNA synthesis in Ehrlich tumor cells by the dialdehyde derivative of inosine (NSC 118994).
Cory JG; Parker SH; Fox CS
Cancer Res; 1978 Mar; 38(3):815-22. PubMed ID: 564236
[No Abstract] [Full Text] [Related]
6. Mode of inhibition of tumor cell ribonucleotide reductase by 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole (NSC 51143).
Cory JG; Fleischer AE
Cancer Res; 1980 Nov; 40(11):3891-4. PubMed ID: 6781737
[TBL] [Abstract][Full Text] [Related]
7. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
Sato A; Cory JG
Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
[TBL] [Abstract][Full Text] [Related]
9. Dialdehyde derivative of 5'-deoxyinosine as a more potent analog of the dialdehyde derivative of inosine (NSC 118994).
Cory JG; Parker SH
Biochem Pharmacol; 1979 Mar; 28(6):867-71. PubMed ID: 454484
[No Abstract] [Full Text] [Related]
10. Control of ribonucleotide reductase in mammalian cells.
Cory JG; Mansell MM; Whitford TW
Adv Enzyme Regul; 1976; 14():45-62. PubMed ID: 987694
[No Abstract] [Full Text] [Related]
11. Inhibition of mammalian ribonucleotide reductase by a dinucleotide produced in eucaryotic cells.
Lewis WH; McNaughton DR; Goh SH; LéJohn HB; Wright JA
J Cell Physiol; 1977 Dec; 93(3):345-52. PubMed ID: 338619
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulation of ribonucleoside diphosphate reductase activity in permeable mouse L cells and in extracts.
Kucera R; Brown CL; Paulus H
J Cell Physiol; 1983 Nov; 117(2):158-68. PubMed ID: 6355126
[TBL] [Abstract][Full Text] [Related]
13. Effect of nucleosides on the synthesis of nucleic acids and proteins in Ehrlich ascites carcinoma cells.
Foltínová I; Kuzela S
Neoplasma; 1976; 23(2):223-6. PubMed ID: 180442
[TBL] [Abstract][Full Text] [Related]
14. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.
Nelson JA; Rose LM; Bennett LL
Cancer Res; 1976 Apr; 36(4):1375-8. PubMed ID: 130972
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones.
Hall IH; Williams WL; Grippo AA; Lee KH; Holbrook DJ; Chaney SG
Anticancer Res; 1988; 8(1):33-42. PubMed ID: 2895992
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the cytidine 5'-diphosphate and adenosine 5'-diphosphate reductase activities of mammalian ribonucleotide reductase.
Cory JG; Mansell MM
Cancer Res; 1975 Sep; 35(9):2327-31. PubMed ID: 167952
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nucleic acid synthesis in Ehrlich tumor cells by periodate-oxidized adenosine and adenylic acid.
Cory JG; Mansell MM; George CB; Wilkinson DS
Arch Biochem Biophys; 1974 Feb; 160(2):495-503. PubMed ID: 4364771
[No Abstract] [Full Text] [Related]
18. Ribonucleotide reductase and DNA synthesis in Ehrlich ascites tumor cells.
Cory JG; Whitford TW
Cancer Res; 1972 Jun; 32(6):1301-6. PubMed ID: 5030829
[No Abstract] [Full Text] [Related]
19. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
Satyamoorthy K; Deshpande SS; Chitnis MP
Neoplasma; 1989; 36(6):673-83. PubMed ID: 2515459
[TBL] [Abstract][Full Text] [Related]
20. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
Albert DA; Gudas LJ
J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
